Cargando…
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
BACKGROUND: The 5-year survival rate of patients with hepatocellular cancer (HCC) was very low because of invasion and metastasis in the early stage. Biomarkers might help predict early occurrence of invasion and metastasis. Accumulating evidence has shown that deleted in liver cancer-1 (DLC1) may b...
Autores principales: | Song, L. J., Liu, Q., Meng, X. R., Li, SH. L, Wang, L. X., Fan, Q. X., Xuan, X. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743322/ https://www.ncbi.nlm.nih.gov/pubmed/26846339 http://dx.doi.org/10.1186/s13000-016-0470-x |
Ejemplares similares
-
Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma
por: Zhang, B, et al.
Publicado: (2013) -
GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
por: Xue, Y, et al.
Publicado: (2014) -
Prognostic analysis of Behçet’s disease with aortic regurgitation or involvement
por: Li, X., et al.
Publicado: (2021) -
Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker
por: Jiao, S-S, et al.
Publicado: (2015) -
α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
por: Zhao, Y, et al.
Publicado: (2017)